Clinical Trials in Ohio

Showing 13301-13320 of 20,938 trials

Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects

NCT03039101

The purpose of this study is to see if the recruitment of a certain cell type (the alpha 4 integrin (CD49d) expressing neutrophil) during a nasal allergen challenge can be inhibited by pretreatment with an FDA approved leukotriene antagonist (montelukast).

Nasal Allergy

Mitchell Grayson25 participantsStarted Sep 2017

Columbus, Ohio, United States

COMPLETEDPhase 232 miles

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

NCT03120520

This is a study of efficacy and safety of Plecanatide in pediatric subjects aged 12 to \< 18 years diagnosed with Chronic Idiopathic Constipation.

Chronic Idiopathic Constipation

Bausch Health Americas, Inc.124 participantsStarted Jan 2017

Foley, Alabama, United States • Jonesboro, Arkansas, United States • Cerritos, California, United States +33 more locations

Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Find Trials by Condition in Ohio

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Building an Optimal Hand Hygiene Bundle

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers

A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)